Work

Phase II study of bi-weekly irinotecan for patients with previously treated HER2-negative metastatic breast cancer: KMBOG0610B

Year: 2011

Type: article

Study design: Clinical Trial

Source: Breast Cancer

DOI: 10.1007/s12282-011-0316-z

Authors: Hidetoshi Hayashi, Junji Tsurutani, Taro Satoh, Norikazu Masuda, Wataru Okamoto, Ryotaro Morinaga, Masaaki Terashima, Masaki Miyazaki, Isamu Okamoto, Yukihiro Nishida, Shusei Tominaga, Yukihiko Tokunaga, Masahide Yamaguchi, Junichi Sakamoto, Takahiro Nakayama, Kazuhiko Nakagawa

Institutions: Kindai University, Osaka National Hospital, Higashi Osaka City General Hospital, Matsushita Memorial Hospital, Nagoya University, The University of Osaka

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1968917525

FWCI: 0.428

Cites: 16

Cited by: 18

Related to: 10